GlassScriptPhysician profile
Richard Thompson
NPI 1891780128
$2,036.94
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $940 · 2021: $338 · 2022: $112 · 2023: $14.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,132.07 | 2019-2021 | |
| Boston Scientific Corporation | $128.31 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $123.62 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $113.41 | 2019-2023 | |
| Astellas Pharma US INC | $99.00 | 2021 | |
| Siemens Medical Solutions USA, INC. | $75.39 | 2020 | |
| Canon Medical Systems USA, INC. | $67.51 | 2019 | |
| Amgen INC. | $43.29 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $37.83 | 2019 | |
| Gilead Sciences, INC. | $29.52 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.55 | 2021 | |
| Sanofi-Aventis U.S. LLC | $22.15 | 2019 | |
| Amarin Pharma, INC. | $12.29 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.